Tagged medicine
Press Release
Manas AI Launches to Transform Discovery of Novel Cancer Medicines
Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI leverages proprietary AI, generative computational chemistry, and best in class biology to cut drug development timelines and costs, transforming cancer and rare disease treatments.
Company raises $24.6 million seed round, co-led by General Catalyst and Reid Hoffman with participation from Greylock, and establishes partnership with Microsoft.
Read More
Press Release
CLS Health Empowers Physicians with Operational Support
CLS Health, the largest physician-owned and physician-led organization in Houston with more than 33 locations, emphasizes the satisfaction and empowerment of its physicians as a key element in delivering exceptional patient care. Read More
Press Release
New Technique Uses Microscopic Bubbles to Blast Cancer With Help From GI Research Foundation
With a $500,000 grant from the GI Research Foundation to Dr. Osman Ahmed, UChicago Medicine will be one of only four hospitals using a new technique to noninvasively treat liver cancer. Read More
Press Release
Research for the Treatment of a 'Black Sheep' Cancer Moves to Human Clinical Trials
With $3.5 million in funding from the GI Research Foundation, a team at the MD Anderson Cancer Center explores a one-two punch to combat BRAF-mutated colorectal cancer and its “dismal prognosis.” Read More
Press Release
Research Shows Cooking Classes Have Positive Impact on Participants’ Microbiome
A University of Chicago team is exploring how a series of cooking classes, focused on nutrition and making better food choices, impact participants’ gastrointestinal microbiomes and overall health. Supported in part by the GI Research Foundation, they are seeing quick improvements to participants’ gut health that may motivate people to keep eating better. Read More
Press Release
FarmaKeio Custom Compounding Enhances Healthcare Services Through Acquisition of State-of-the-Art Compounding Pharmacy
Former site of US Compounding is acquired by up-and-comer in custom compounded pharmaceuticals, FarmaKeio, as part of ongoing expansion to support availability and delivery of custom compounded medications nationwide. Read More
Press Release
Healing the Wounds of Inflammatory Bowel Disease
A University of Chicago team identified a special type of stem cell that heals damaged bowel tissue in mice, a discovery that may have direct application to humans with inflammatory bowel disease. These early findings, made possible with seed funding from the GI Research Foundation, resulted in a recent five-year, $2.5 million grant from the National Institutes of Health to study those cells in humans. Read More
Press Release
iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology
iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases. Manufacturing agreement supports advancement of iTolerance's development of iTOL-100 towards first in human clinical study for lead program, iTOL-102. Read More
Press Release
FarmaKeio Outsourcing Announces Patented Formulation of Revolutionary Hormone Therapy Pellet
FarmaKeio Outsourcing is proud to announce the release of its latest innovation, the only patented hormone pellet with triamcinolone developed in an FDA-registered 503B outsourcing facility. The pellet is set to provide a new and revolutionary solution to hormone replacement therapy for men and women. Read More
Press Release
